Editorial Comment: Duration of Axillary Lymphadenopathy After COVID-19 Vaccine Booster Administration
- PMID: 36946901
- DOI: 10.2214/AJR.23.29309
Editorial Comment: Duration of Axillary Lymphadenopathy After COVID-19 Vaccine Booster Administration
Comment on
-
Axillary Lymphadenopathy After a COVID-19 Vaccine Booster Dose: Time to Resolution on Ultrasound Follow-Up and Associated Factors.AJR Am J Roentgenol. 2023 Aug;221(2):175-183. doi: 10.2214/AJR.22.28970. Epub 2023 Mar 8. AJR Am J Roentgenol. 2023. PMID: 36883774
Similar articles
-
Axillary Lymphadenopathy After a COVID-19 Vaccine Booster Dose: Time to Resolution on Ultrasound Follow-Up and Associated Factors.AJR Am J Roentgenol. 2023 Aug;221(2):175-183. doi: 10.2214/AJR.22.28970. Epub 2023 Mar 8. AJR Am J Roentgenol. 2023. PMID: 36883774
-
Editorial Comment: Prolonged Resolution of COVID-19 Vaccine-Related Axillary Lymphadenopathy Necessitates a Long Imaging Follow-Up Interval.AJR Am J Roentgenol. 2022 Oct;219(4):567. doi: 10.2214/AJR.22.28019. Epub 2022 Jun 1. AJR Am J Roentgenol. 2022. PMID: 35642766 No abstract available.
-
Axillary lymphadenopathy following bivalent COVID-19 booster vaccination.Clin Imaging. 2023 Mar;95:52-55. doi: 10.1016/j.clinimag.2022.12.003. Epub 2022 Dec 15. Clin Imaging. 2023. PMID: 36610271 Free PMC article. No abstract available.
-
Management of Unilateral Axillary Lymphadenopathy Detected on Breast MRI in the Era of COVID-19 Vaccination.AJR Am J Roentgenol. 2021 Oct;217(4):831-834. doi: 10.2214/AJR.21.25604. Epub 2021 Feb 5. AJR Am J Roentgenol. 2021. PMID: 33543649 Review.
-
Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality.Eur J Radiol. 2022 Jul;152:110334. doi: 10.1016/j.ejrad.2022.110334. Epub 2022 Apr 30. Eur J Radiol. 2022. PMID: 35512513 Free PMC article. Review.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
